PhytoHealth (TPE:4108) Moat Score: 0/10 (As of Jul. 09, 2026)


TPE:4108 PhytoHealth Corp TPE:4108
72 GF Score
Price NT$12.00
GF Value NT$15.95
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PhytoHealth Moat Score?

PhytoHealth has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

PhytoHealth has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes PhytoHealth might have No Moat - No discernible moat.

PhytoHealth  (TPE:4108) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

PhytoHealth Moat Score Related Terms

TPE:4108
72GF Score
PhytoHealth Corp TPE:4108
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PhytoHealth (TPE:4108) Overvalued in 2026?

Based on GuruFocus' analysis, PhytoHealth stock appears to be undervalued. The current stock price of NT$12.00 is trading 24.8% below its estimated GF Value™ of NT$15.95. GuruFocus considers PhytoHealth to be Modestly Undervalued.

Key valuation signals for TPE:4108:

  • Moat Score: 0
  • GF Value™: NT$15.95 vs. price of NT$12.00 (24.8% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the TPE:4108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PhytoHealth Business Description

Address Fuxing North Road, No. 167, 5th Floor - 1, Zhongshan District, Taipei, TWN, 104
PhytoHealth Corp engages in the research and development, production, manufacture, and sale of pharmaceutical drugs, cosmetics, Class B drugs, and dietary supplements. The company's product portfolio comprises White Blood Crystals Injection, White Pain Relief Soft Capsules, WhiteGilead, and White AminoSpeed supplements. Additionally, it is developing PHN031 (White Bone) for the prevention of osteoporosis; PHN033 (White Sugar) for the treatment of diabetic nephropathy; PHN016 for cancer treatment; and PHN017 for the treatment of cytokine storm. The company's reportable operating segments are: Pharmaceutical drugs and dietary supplement, which generate maximum revenue, Medical diagnostic products, and Precision medical equipment. Geographically, it derives maximum revenue from Taiwan.
72GF Score

Get the complete analysis for TPE:4108

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$12.00
Price
NT$15.95
GF Value